Physician profile
Ran Wang
NPI 1558854364
$4,974.10
in general payments reported to CMS, 2019-2025
18 companies · $154 in 2025
The $154 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $362 · 2020: $73.46 · 2021: $530 · 2022: $2,634 · 2023: $372 · 2024: $848 · 2025: $154.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,287 · Education: $86.66.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,287.48 |
| Education | $86.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,542.83 | 2019-2023 | Xpress Ent Dilation System, Xerogel Nasal/Epistaxis 2 Pack, Latera |
| Medtronic, INC. | $416.10 | 2024 | Fusion, Stealthstation S8 Platform |
| Inspire Medical Systems, INC. | $412.72 | 2022-2024 | Inspire |
| Depuy Synthes Sales INC. | $266.89 | 2020-2023 | Matrixmandible |
| Regeneron Healthcare Solutions, INC. | $247.81 | 2022-2025 | Dupixent |
| Genzyme Corporation | $149.99 | 2024 | |
| Acclarent, INC | $147.29 | 2019 | |
| Intersect Ent, INC. | $143.63 | 2021 | |
| Optinose US, INC. | $136.15 | 2023 | |
| Integra Lifesciences Corporation | $131.82 | 2021-2024 | Cusa Clarity, Codman Certas, Codman Hakim |
| Medical Device Business Services, INC. | $118.54 | 2021 | |
| Axogen | $78.67 | 2020-2021 | |
| Zimmer Biomet Holdings, INC. | $51.16 | 2019 | |
| Cochlear Americas | $39.29 | 2019-2022 | |
| Medtronic USA, INC. | $33.83 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exelixis INC. | $21.65 | 2025 | Cabometyx |
| Kerecis Limited | $19.71 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Merck Sharp & Dohme LLC | $16.02 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ran Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.